Design and synthesis of a screening library using the natural product scaffold 3-chloro-4-hydroxyphenylacetic acid. Journal of Natural Products, 78(4), pp. 914-918. In regard to NP drug discovery, a scaffold is a basic structural element that contains mono-or poly-functional groups that can be exploited in the synthesis of chemically diverse and unique screening libraries. Owing to the limited biological profiling of the original 3-chloro-4-hydroxyphenyl acetic acid-derived library 15 it was decided to make additional synthetic analogues for a more thorough evaluation in several biological assays.
Natural products (NPs) have played a key role in drug discovery, which is reflected by the fact that numerous commercial drugs are either NPs, modified NPs, or compounds based on a NP pharmacophore. [1] [2] [3] [4] The success and impact of NPs in the pharmaceutical arena is due, in part, to the fact that these natural constituents have been biologically validated, since they have been selected during evolution to bind to biosynthetic enzymes. [5] [6] [7] This inherent capacity of NPs to interact in biological space is thought to correlate with their ability to recognize therapeutic targets present in humans and/or other organisms (e.g., pathogenic microbes) that are associated with human diseases. 5, 8, 9 In regard to NP drug discovery, a scaffold is a basic structural element that contains mono-or poly-functional groups that can be exploited in the synthesis of chemically diverse and unique screening libraries. The ultimate goal of such libraries is the identification of hit or lead compounds [usually following high-throughput screening (HTS)] that can be further optimized using medicinal chemistry for potential preclinical development and beyond. The use of selected NP scaffolds as the starting points for the generation of novel libraries has been touted as a means by which NPs can impact present and future drug discovery and development programs. 3, 4, [10] [11] [12] On the basis of this hypothesis, one of our current research objectives is the design and synthesis of "smarter" lead or drug-like screening libraries based on unique NP scaffolds isolated from Australian biota sources. To date, we have synthesized libraries based on the muurolane (source: plant), 4 tetrahydroanthraquinone (source: mushroom), 13 tambjamine (source: ascidian) 14 and 3-chloro-4-hydroxyphenylacetic acid (1) (source: endophytic fungus) 15 NP scaffolds.
As part of our continuing research efforts in this field it was decided to evaluate further and exploit the 3-chloro-4-hydroxyphenyl acetic acid (1) scaffold in medicinal chemistry studies.
In this second generation library, careful consideration was given to the design aspect of the library, paying particular attention to creating molecules with desirable drug-like physicochemical properties, based on Lipinski's "Rule of Five" criteria. 16 Furthermore, it was desired to investigate an alternative amidation reaction compared to the original library procedure, 15 in an attempt to improve yields, and potentially simplify the reaction product work-up. The fungal NP, 3-chloro-4-hydroxyphenyl acetic acid (1), was first isolated from the endophytic microfungus Xylaria sp.
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Although this NP has shown minimal activity towards human melanoma (MM96L) and prostate (DU145) cell lines, 15 and carbonic anhydrase, 15 the 3-chloro-4-hydroxyphenyl motif present in 1 has been identified in a number of bioactive molecules such as (-)-xylariamide A, 18 coniothyriomycin, 19 and cryptophycin 53. 20, 21 Owing to the limited biological profiling of the original 3-chloro-4-hydroxyphenyl acetic acid-derived library 15 it was decided to make additional synthetic analogues for a more thorough evaluation in several biological assays.
Herein the solution-phase parallel synthesis of a 20-membered amide library (3-22) using a derivative of the fungal metabolite, 3-chloro-4-hydroxyphenyl acetic acid (1) is reported. The biological evaluation of the library against malaria and trypanosome parasites, along with a prostate cancer cell lines is also described.
A large percentage of NPs and synthetic compounds possess the amide functional group and it is also known that ~25% of clinical drugs contain this moiety thus making the amidation reaction the most commonly used reaction in medicinal chemistry. 22 A number of reviews have been published demonstrating the use and importance of coupling agents (e.g., HBTU, EDCI, CDI, and DCC) for amide formation. 23, 24 However, for the synthesis of this second generation amide library, an amidation reaction was used whereby the products were prepared by direct aminolysis of an ester with a range of primary amines under solvent-free conditions. 25, 26 The previous amidation study on the NP scaffold (1) reported the synthesis of a small 11-membered library using EDCI coupling. 15 Following liquid-liquid partitioning of the crude reaction product and silica flash chromatography, the yields from the EDCI first generation library ranged from 8 to 99%.
Prior to commencing the synthesis of the second generation library, a 25-membered virtual analogue (VA) library was constructed using a set of commercial amines. Using the software Instant JChem, 27 the physicochemical parameters such as cLog P, hydrogen bond donors (HBD), hydrogen bond acceptors (HBA), and molecular weight (MW) of these VAs (VA1-VA20) were determined (see Supporting Information, Table S45 and Figure S46 ). The molecules with favourable physicochemical properties, based on Lipinski's "Rule of Five" for drug-like molecules (MW < 500, HBD < 5, HBA < 10, cLog P < 5) 16 (see Supporting   Information Table S47 ) were prioritized for synthesis work. On the basis of the in silico data, VA1-VA20 were selected for synthesis since all these analogues had no "Rule of Five" violations.
The synthetic route for the target amide analogues is shown in Scheme 1. The carboxylic acid moiety of the commercially available scaffold 1 was activated by esterification with anhydrous MeOH in the presence of p-toluenesulfonic acid (pTsOH) yielding methyl(3-chloro-4-hydroxyphenyl)acetate (2), which is more susceptible to aminolysis under mild conditions. Treatment of 2 with 20 primary amines afforded the secondary amides (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) as shown in Figure 1 . Excess amine was removed under N 2 and/or by high vacuum after which the crude reaction mixture was pre-adsorbed onto silica gel and chromatographed using CH 2 Cl 2 -MeOH or CH 2 Cl 2 -MeOH-1% triethylamine (TEA) (see Experimental Section) to afford compounds 3-22 in moderate to good yields. Compounds 3 and 9 have been synthesized previously using EDCI as the coupling agent with the yields of 98% and 69%, respectively. 15 However, using the direct aminolysis method, 3 (73%) and 9
(25%) were obtained in reduced yields when compared to the EDCI coupling procedure. Despite the lower yields, direct aminolysis under solvent-free conditions proved to be a simple and clean reaction that avoided the use of coupling reagents and complicated work-up procedures. Thus, this methodology is well suited for combinatorial chemistry studies using the scaffold, methyl(3-chloro-4-
The structures of all the amide analogues (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) were determined following 1D ( 1 H and 13 C) and 2D NMR (gCOSY, gHSQC, gHMBC) and HRESIMS data analysis. Slow evaporation of solutions of 8, 12, and 22 in CH 2 Cl 2 resulted in crystals suitable for X-ray diffraction. Therefore, the structures of compounds 8, 12, and 22
were also confirmed by X-ray crystallography (see Figure 2 and Supporting Information S48 and Figure S49 ).
Owing to an ongoing interest in the discovery and development of novel small molecules that have potential anticancer [28] [29] [30] and/or anti-infective [31] [32] [33] properties the library (3-22) was profiled along with the NP scaffold (1), and methyl ester derivative (2) against a human prostate cancer cell line (LNCaP), 28 as well as Trypanosoma brucei brucei 34 and Plasmodium falciparum. 35 These in vitro assays showed that none of the compounds displayed significant activity (>50% inhibition) after 72 h at 10
M. Additionally, all the analogues were also tested at 10 M for effects on the lipid anhydrous MeOH (1 mL), and a crystal of pTsOH was added and the mixture was stirred at room temperature for 48 h. 40, 41 Excess solvent was removed under N 2 and the resulting crude mixture was partitioned between CH 2 Cl 2 (2 × 100 mL) and saturated NaHCO 3 (100 mL). The Two different purification conditions were used during these studies. The first method was applied to the neutral amide analogues (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) 
